Cidara Therapeutics, Inc. (CDTX)
Jan 7, 2026 - CDTX was delisted (reason: acquired by MRK)
221.38
+0.06 (0.03%)
Inactive · Last trade price on Jan 6, 2026

Cidara Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20
-----0.30.972.769.225.0926.1110.2240.746.227.117.237.0832.862.413.73
Revenue Growth (YoY)
------94.07%-96.27%-73.03%-77.38%-18.12%267.24%41.44%475.81%-81.08%195.22%93.75%192.88%868.84%-4.82%105.46%
Gross Profit
-----0.30.972.769.225.0926.1110.2240.746.227.117.237.0832.862.413.73
Selling, General & Admin
8.16.56.187.314.974.753.63.453.33.184.463.65.784.075.24.984.614.374.784.15
Research & Development
80.5324.8224.646.8712.4391.545.928.0110.398.6618.8720.1120.0415.2620.1719.0120.5117.7215.8521.13
Other Operating Expenses
-3.945.51-----------------
Total Operating Expenses
88.6335.2536.2954.1817.3996.299.5211.4613.6911.8423.3323.7125.8219.3325.372425.1122.0920.6325.28
Operating Income
-88.63-27.38-25.27-54.18-17.39-95.98-8.54-8.7-4.47-6.752.78-13.4914.92-13.11-18.26-16.77-18.0410.77-18.22-21.55
Interest Income
5.41.671.91.811.861.770.370.530.610.620.230.160.06-0.01-0.02-0.03-0.05---
Interest Expense
------------------0.06-0.07-0.09
Other Non-Operating Income (Expense)
---0.11-----------------
Total Non-Operating Income (Expense)
5.41.671.791.811.861.770.370.530.610.620.230.160.06-0.01-0.02-0.03-0.05-0.06-0.07-0.09
Pretax Income
-83.23-25.72-23.48-52.37-15.54-94.21-8.18-8.17-3.86-6.133.01-13.3314.98-13.12-18.28-16.8-18.0810.71-18.29-21.63
Provision for Income Taxes
-------0.01-0.030.04-0.27--------
Net Income
-83.23-25.72-23.48-52.37-15.54-94.21-8.18-8.18-3.82-6.173.01-13.614.98-13.12-18.28-16.8-18.0810.71-18.29-21.63
Earnings From Discontinued Operations
---0.06-0.453-2.154.97-5.28-7.46----------
Net Income to Common
-83.23-25.72-23.48-52.31-15.99-91.21-10.33-3.21-9.11-13.623.01-13.614.98-13.12-18.28-16.8-18.0810.71-18.29-21.63
Shares Outstanding (Basic)
271614107555555443332222
Shares Outstanding (Diluted)
271614107555555443332322
Shares Change (YoY)
311.67%240.67%212.44%114.97%44.65%1.16%-10.31%25.88%1.91%30.51%48.51%11.51%78.85%16.54%45.08%46.03%14.64%45.83%48.60%28.97%
EPS (Basic)
-3.10-1.65-1.66-5.37-2.45-20.65-1.80-0.71-0.85-3.020.60-3.803.40-3.80-5.40-5.20-7.403.60-7.80-9.80
EPS (Diluted)
-3.10-1.65-1.66-5.37-2.45-20.65-1.80-0.71-0.85-3.020.60-3.803.40-3.80-5.40-5.20-7.403.60-7.80-9.80
Free Cash Flow
-40.62-40.96-21.95-29.47-36.8-103.79-6.67-12.9-1.762.72-10.99-21.0127.96-11.85-23.69-14.91-11.983.42-1.81-11.16
Free Cash Flow Per Share
-1.51-2.63-1.55-3.03-5.64-22.74-1.47-2.85-0.390.60-2.17-5.846.31-3.43-6.95-4.63-4.841.15-0.77-5.05
Gross Margin
-----100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
------31782.78%-877.90%-315.71%-48.48%-132.57%10.65%-131.98%36.63%-210.96%-256.87%-232.11%-254.89%32.78%-756.73%-577.85%
Profit Margin
------31195.36%-840.39%-296.84%-41.48%-121.12%11.54%-133.06%36.76%-211.05%-257.15%-232.57%-255.55%32.59%-759.63%-580.16%
FCF Margin
------34368.05%-685.20%-468.07%-19.10%53.34%-42.10%-205.61%68.63%-190.67%-333.27%-206.41%-169.36%10.42%-74.96%-299.14%
EBITDA
-88.6-27.35-25.22-54.12-17.33-95.93-8.49-8.66-4.44-6.722.81-13.4614.96-13.08-18.22-16.73-17.9910.82-18.17-21.48
EBITDA Margin
------31763.91%-872.15%-314.30%-48.20%-132.08%10.77%-131.70%36.72%-210.34%-256.32%-231.60%-254.25%32.93%-754.36%-576.05%
EBIT
-88.63-27.38-25.27-54.18-17.39-95.98-8.54-8.7-4.47-6.752.78-13.4914.92-13.11-18.26-16.77-18.0410.77-18.22-21.55
EBIT Margin
------31782.78%-877.90%-315.71%-48.48%-132.57%10.65%-131.98%36.63%-210.96%-256.87%-232.11%-254.89%32.78%-756.73%-577.85%
Effective Tax Rate
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.09%0.83%-0.65%0.00%-2.04%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q